通过结合CRISPRa介导的内源性Gata4激活和外源Mef2c和Tbx5表达的直接心脏重编程

相关实验视频

Updated: May 18, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

Peisen Huang^1,2, Jun Xu^1,2, Benjamin Keepers^1,2

¹McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Molecular therapy. Nucleic acids

|December 25, 2024

概括

科学家使用CRISPR激活来促进内源基因表达,通过激活GATA4成功将纤维细胞转化为诱导心肌细胞 (iCMs). 这减少了对心脏再生的病毒载体的依赖.

科学领域:

心血管生物学心血管生物学
基因编辑技术的技术
再生医学是一种再生医学.

背景情况:

直接的心脏重编程通过转录因子 (TF) 将纤维细胞转化为诱导心肌细胞 (iCMs).
TFs的病毒载体传递带有基因组突变和免疫反应等风险,限制了临床使用.
激活内源性TF提供了一个比外源性TF交付更安全的替代方案.

研究的目的:

为了研究CRISPR激活 (CRISPRa) 对于交换激活内源心脏重编程因子 (MEF2C,GATA4,TBX5).
评估CRISPRa在诱导来自小鼠和人类纤维细胞的iCMs中的有效性.
探索一种新的心脏再生策略,减少对外部因素的依赖.

主要方法:

使用修改后的CRISPRa/dCas9系统来向内源MEF2C,GATA4和TBX5.5的促进剂和增强剂.
选单导向RNAs (sgRNAs),以确定那些能够激活TF基因表达的人.
结合CRISPRa介导的GATA4激活与外源MEF2C和TBX5表达.

主要成果:

确定了有效激活内源GATA4表达的sgRNAs.
通过使用CRISPRa激活的GATA4以及外源MEF2C和TBX5.5成功地将纤维细胞转化为iCMs.
观察到对内源MEF2C和TBX5的CRISPRa介导的交换活化效果有限,可能是由于表观遗传障碍.

结论:

通过CRISPRa介导的内源GATA4的激活,与外源MEF2C和TBX5相结合,为减少对心脏重编程中的外源因素的依赖提供了概念证明.
这种方法提供了一个新的战略,用于将痕形成纤维细胞转化为iCMs用于再生医学.
需要进一步的技术改进,才能实现仅通过CRISPR (所有内源因素的激活) 重编程.

关键词:

这就是CRISPRdCas9系统.许多MGTGT的产品.MT:RNA/DNA编辑编辑通过直接的心脏重编程.内源性交易的激活.导向RNA指导RNA是指导RNA的指导RNA.

更多相关视频

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

相关概念视频

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.